Recommendations of diagnosis and treatment of primary Sj?gren′s syndrome in China / 中华内科杂志
Chinese Journal of Internal Medicine
; (12): 269-276, 2020.
Article
in Zh
| WPRIM
| ID: wpr-870152
Responsible library:
WPRO
ABSTRACT
Sj?gren′s syndrome is a chronic systemic autoimmune disease characterized by lymphocyte proliferation and progressive exocrine gland damage. In China, standardized diagnosis and treatment for Sj?gren′s syndrome lags behind other common rheumatic diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Based on the evidence and guidelines from China and other countries, Chinese Sj?gren′s Syndrome Collaborative Research Group together with stomatologist and ophthalmologist developed Standardization of diagnosis and treatment of primary Sj?gren′s syndrome. The purposes are: (1) to standardize the detection and interpretation of key indicators for the diagnosis of Sj?gren's syndrome, including serum anti SSA antibody and labial gland pathology; (2) to suggest using widely accepted disease activity index in evaluation of the disease; (3) to standardize rational management for Sj?gren′s syndrome patients with topical and systemic diseases.
Full text:
1
Index:
WPRIM
Type of study:
Diagnostic_studies
/
Guideline
Language:
Zh
Journal:
Chinese Journal of Internal Medicine
Year:
2020
Type:
Article